Reclaim Your Health Ignite Your Freedom!
Embrace Life Beyond Nicotine
SpaceRx is developing the first once-daily oral smoking cessation medication and advanced platform medical devices.
Our products are designed to support individuals in reaching their personal goals by focusing on simplicity and effectiveness to improve patient compliance and deliver life-changing outcomes.
Founded
2021
Received nearly
$700K
in non-dilutive funding
Current Stage
Pre-Clinical
IND-enabling development
SMOKING IS BAD
SMOKING IS BAD
We all know smoking is bad for your health. It is a major health crisis with no existing sustainable treatment.
In the United States, over 28.3 million adults still smoke cigarettes, making it the leading cause of preventable disease and disability. Tragically, smoking accounts for 1 in 5 deaths every year.
We are building the solutions.
Since the FDA's approval of Chantix® in 2006, there has been little innovation in smoking cessation treatments. We need new, effective solutions now more than ever.
Our groundbreaking New Chemical Entity offers a game-changing advancement. Designed for once-daily administration, it simplifies treatment, enhances patient compliance, and drives better outcomes.
Additionally, our Electronic Delivery of Inhaled Therapeutics (EDIT) device allows better management of breakthrough cravings and reduces overall stress.
Together, we can create a healthier, smoke-free future.
Our Pipeline
A $28 Billion Opportunity: Redefining Nicotine Replacement Therapy
The global nicotine replacement therapy (NRT) market is valued at an impressive $28 billion—and we’re poised to make a significant impact.
With our innovative solutions, we aim to redefine the standard of care, seize market share, and transform the future of smoking cessation.
Break Free, Stay Free
Focusing on Your Health
Within minutes of smoking your last cigarette, your body begins to recover
Statistics from the American Cancer Society
20
Minutes
Your heart rate and blood pressure drop.
12
Hours
CO2 levels in your blood drop to normal.
2
Weeks
Your circulation improves and lung function increases.
1
Year
Your risk of heart disease is cut in half.
10
Years
You’re half as likely to die of lung cancer than those still smoking.
Meet Our Team
Management Team
Peter Lee
Founder & Chief Executive Officer
Gerri Kim
Director of Communications
and Patient Advocacy
Scientific Founders
J. Nicholas Betley, PhD
Erin Clark, PhD
Eduardo Martinez, PhD
Vice President of Drug Discovery
Katrine Thor Andersen, MBA
Chief Strategy Officer
Supported By:
We are grateful for NIH NIDA’s continued support and partnership with multiple SBIR/STTR awards to advance both projects toward impactful outcomes.
Contact us.
We’re always looking for collaborators, investors, and other partners. Let us know how we can work together!
Hello@SpaceRX.xyz
Located in Reston, Virginia, USA
